Scientists present that lecanemab clears amyloid plaques by partaking microglia by its Fc fragment, defining the mobile program behind its therapeutic impact Lecanemab, marketed as Leqembi, is a monoclonal antibody therapy for Alzheimer’s illness that reduces the buildup of poisonous amyloid plaques within the mind and slows cognitive decline. Scientists from VIB and KU Leuven […]
Source link
The children, work deadlines, what’s for dinner… these are the sorts of issues that always occupy our ideas. What’s occurring inside our cells? Not a lot. Nonetheless, our...
Read more










